Atlas Trials

A Study of LY2886721 in Healthy Participants and Participants Diagnosed With Alzheimer's Disease

Clinical trial NCT01807026 · COMPLETED

Trial details

NCT number
NCT01807026
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer DiseaseHealthy Volunteers
Start date
2013-03-01
Primary completion
2013-05-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.